Literature DB >> 14614561

IA-2 is not required for the development of diabetes in NOD mice.

A Kubosaki, J Miura, Abner L Notkins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14614561     DOI： 10.1007/s00125-003-1252-z

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  9 in total

1.  The NOD mouse model of type 1 diabetes: as good as it gets?

Authors:  M A Atkinson; E H Leiter
Journal:  Nat Med       Date:  1999-06       Impact factor: 53.440

Review 2.  Immunologic and genetic factors in type 1 diabetes.

Authors:  Abner Louis Notkins
Journal:  J Biol Chem       Date:  2002-09-20       Impact factor: 5.157

3.  IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus.

Authors:  M S Lan; C Wasserfall; N K Maclaren; A L Notkins
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

4.  ICA69(null) nonobese diabetic mice develop diabetes, but resist disease acceleration by cyclophosphamide.

Authors:  Shawn Winer; Igor Astsaturov; Roger Gaedigk; Denise Hammond-McKibben; Marc Pilon; Aihua Song; Violetta Kubiak; Wolfram Karges; Enrico Arpaia; Colin McKerlie; Peter Zucker; Bhagirath Singh; H-Michael Dosch
Journal:  J Immunol       Date:  2002-01-01       Impact factor: 5.422

5.  Mapping to chromosomes 1 and 12 of mouse homologs of human protein tyrosine phosphatase, receptor-type, related genes encoding pancreatic beta cell autoantigens.

Authors:  E H Leiter; H Tsumura; D V Serreze; H D Chapman; D U Rabin; M S Lan; A L Notkins
Journal:  Mamm Genome       Date:  1997-12       Impact factor: 2.957

6.  Targeted disruption of the protein tyrosine phosphatase-like molecule IA-2 results in alterations in glucose tolerance tests and insulin secretion.

Authors:  Keiichi Saeki; Min Zhu; Atsutaka Kubosaki; Jingping Xie; Michael S Lan; Abner Louis Notkins
Journal:  Diabetes       Date:  2002-06       Impact factor: 9.461

7.  Glutamate decarboxylase and GABA in pancreatic islets: lessons from knock-out mice.

Authors:  S F Kash; B G Condie; S Baekkeskov
Journal:  Horm Metab Res       Date:  1999-05       Impact factor: 2.936

Review 8.  International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice.

Authors:  E Bonifacio; M Atkinson; G Eisenbarth; D Serreze; T W Kay; E Lee-Chan; B Singh
Journal:  Diabetes       Date:  2001-11       Impact factor: 9.461

9.  Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes.

Authors:  S Trembleau; G Penna; S Gregori; G Magistrelli; A Isacchi; L Adorini
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422
  9 in total
  18 in total

Review 1.  Insulin as a key autoantigen in the development of type 1 diabetes.

Authors:  Maki Nakayama
Journal:  Diabetes Metab Res Rev       Date:  2011-11       Impact factor: 4.876

2.  An immunologic homunculus for type 1 diabetes.

Authors:  Dirk Homann; George S Eisenbarth
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

3.  Conserved T cell receptor alpha-chain induces insulin autoantibodies.

Authors:  Masakazu Kobayashi; Jean Jasinski; Edwin Liu; Marcella Li; Dongmei Miao; Li Zhang; Liping Yu; Maki Nakayama; George S Eisenbarth
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-14       Impact factor: 11.205

Review 4.  Autoimmune Responses to Exosomes and Candidate Antigens Contribute to Type 1 Diabetes in Non-Obese Diabetic Mice.

Authors:  Yang D Dai; Huiming Sheng; Peter Dias; M Jubayer Rahman; Roman Bashratyan; Danielle Regn; Kristi Marquardt
Journal:  Curr Diab Rep       Date:  2017-10-28       Impact factor: 4.810

5.  Islet-Derived CD4 T Cells Targeting Proinsulin in Human Autoimmune Diabetes.

Authors:  Aaron W Michels; Laurie G Landry; Kristen A McDaniel; Liping Yu; Martha Campbell-Thompson; William W Kwok; Kenneth L Jones; Peter A Gottlieb; John W Kappler; Qizhi Tang; Bart O Roep; Mark A Atkinson; Clayton E Mathews; Maki Nakayama
Journal:  Diabetes       Date:  2016-12-05       Impact factor: 9.461

6.  Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice.

Authors:  Maki Nakayama; Norio Abiru; Hiroaki Moriyama; Naru Babaya; Edwin Liu; Dongmei Miao; Liping Yu; Dale R Wegmann; John C Hutton; John F Elliott; George S Eisenbarth
Journal:  Nature       Date:  2005-05-12       Impact factor: 49.962

7.  Banting Lecture 2009: An unfinished journey: molecular pathogenesis to prevention of type 1A diabetes.

Authors:  George S Eisenbarth
Journal:  Diabetes       Date:  2010-04       Impact factor: 9.461

8.  Cutting Edge: Nonobese Diabetic Mice Deficient in Chromogranin A Are Protected from Autoimmune Diabetes.

Authors:  Rocky L Baker; Brenda Bradley; Timothy A Wiles; Robin S Lindsay; Gene Barbour; Thomas Delong; Rachel S Friedman; Kathryn Haskins
Journal:  J Immunol       Date:  2015-11-25       Impact factor: 5.422

Review 9.  Antigen-based vs. systemic immunomodulation in type 1 diabetes: the pros and cons.

Authors:  Sofie Robert; Hannelie Korf; Conny Gysemans; Chantal Mathieu
Journal:  Islets       Date:  2013-03-01       Impact factor: 2.694

Review 10.  Type 1 diabetes: primary antigen/peptide/register/trimolecular complex.

Authors:  Tomasz Sosinowski; George S Eisenbarth
Journal:  Immunol Res       Date:  2013-03       Impact factor: 2.829
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.